期刊文献+

环氧合酶-2基因-1195G>A多态性位点与缺血性脑卒中患者阿司匹林抵抗的相关性 被引量:6

Correlation between Single Nucleotide Polymorphism of-1195G >A of COX-2 Gene and Aspirin Resistance in Patients with Ischemic Stroke
暂未订购
导出
摘要 目的:探讨环氧合酶-2(COX-2)基因-1195 G<A多态性位点与缺血性脑卒中(IS)患者阿司匹林抵抗(AR)的相关性。方法:纳入中国北方汉族IS患者210例,根据血小板聚集率分为阿司匹林敏感(AS)组147例,非AS组63例。采用扩增阻碍突变系统(ARMS)结合TaqMan探针的实时荧光定量PCR方法检测-1195 G<A多态性。结果:-1195G<A位点基因型、显性模型分布频率在AS组及非AS组中差异均无统计学意义(P>0.05);非AS组中-1195G<A位点(GA+AA)基因型频率及A等位基因频率高于AS组,差异均有统计学意义(x^2=4.96,=0.03;x^2=5.50,P=0.02);多因素分析提示,与GG基因型相比,COX-2的-1195G<A位点(GA+AA)基因型发生AR可能性更大(OR=2.41,95%CI为1.09—5.37,P=0.03)。结论:COX-2基因—1195G〉A位点遗传变异与可能Is患者发生AR相关,可能是AR发生的一个遗传易感性位点。 ObjectiveTo study the correlation between single nucleotide polymorphisms (SNPs) of-1195G〈A of cyclooxygenase-2 (COX-2) gene and Aspirin resistance (AR) in patients with ischemic stroke (IS). Methods:According to the rate of platelet aggregation, 210 northern Chinese Han patients with IS were divided into Aspirin sensitivity (AS) group (147 cases) and non-Asgroup [17 AR cases, and 46 Aspirin semi-resistance (ASR) cases] (n=63). The SNPs were detected by Amplification mutation system (ARMS) combined with TaqMan probe in a real-time PCR. Results:There were no significant differences in the genotype, allele, additive or recessive model frequencies of-1195G〈A polymorphisms between the 2 groups. The significant difference between (GA+AA) and GG genotype frequencies of-1195G〈A polymorphisms were observed in groups of AS and non-AS (P =0.03). For A allele of-1195G〈A, there was also a significant difference between the two groups (P =0.02). On multivariate analysis controlling for conventional vascular risk factors, the-1195 GA and AA genotypes were identified inde-pendently to be related with (ASR+AR) ( OR=2.41,:1.07-5.42, =0.03). Conclusion:-1195G〈A poly-morphism of COX-2 gene was associated with AR or ASR in patients with IS, which may be a genetic predisposi-tion to phenotypes of AR or ASR.
出处 《神经损伤与功能重建》 2014年第2期111-114,共4页 Neural Injury and Functional Reconstruction
关键词 环氧合酶-2 缺血性脑卒中 阿司匹林抵抗 cyclooxygenase-2 ischemic stroke Aspirin resistance
  • 相关文献

参考文献15

  • 1Antithrombotic Trialists1 Collaboration.Collabo-rative meta-analysis of randomised trials of an-tiplatelet therapy for prevention of death,myocardialinfarction,and stroke in high risk patients[J].BMJ,2002,324:71-86.
  • 2McKee SA,Sane DC,Deliargyris EN.Aspirin re-sistance in cardiovascular disease:a review of preva-lence,mechanisms,and clinical significance[J].Thromb Haemost,2002,88:711-715.
  • 3Zheng AS,Churilov L,Colley RE,et al.Associa-tion of aspirin resistance with increased stroke severityand infarct size[J].JAMA Neurol,2013,70:208-213.
  • 4O'Donnell CJ,Larson MG,Feng D,et al.Geneticand environmental contributions to platelet aggrega-tion:the Framingham heart study[J].Circulation,2001,103:3051-3056.
  • 5Sharma V,Kaul S,Al-Hazzani A,et al.Associa-tion of COX-2 rs20417 with aspirin resistance[J].JThromb Thrombolysis,2013,35:95-99.
  • 6中国急性缺血性脑卒中诊治指南2010[J].中华神经科杂志,2010,43(2):146-153. 被引量:3401
  • 7Gum PA,Kottke-Marchant K,Poggio ED,et al.Profile and prevalence of aspirin resistance in patientswith cardiovascular disease[J].Am J Cardiol,2001,88:230-235.
  • 8Patrono C.Aspirin resistance:definition,mecha-nisms and clinical read-outs[J].J Thromb Haemost,2003,I:1710-1713.
  • 9Narvaez I,Sagastagoitia JD,Vacas M,et al.Prevalence and biologic profile of aspirin resistance inpatients with angiographically proven coronary arterydisease[J].Thromb Res,2007,120:671-677.
  • 10Canivano Petrenas L,Garcia Yubero C.Resis-tance to aspirin:prevalence,mechanisms of action andassociation with thromboembolic events.A narrativereview[J].Farm Hosp,2010,34:32-43.

二级参考文献27

共引文献3413

同被引文献86

  • 1全锦花,张新超,蔡剑平,何青,许锋,戴大鹏.急性冠状动脉综合征患者血小板内皮细胞粘附分子1基因多态性分析[J].中国动脉硬化杂志,2007,15(2):120-124. 被引量:2
  • 2中华神经科学会 中华神经外科学会.各类脑血管病诊断要点.中华神经科杂志,1996,:379-380.
  • 3Hamberg M, Svensson J, Samuelsson B. Thromboxanes:a new group of biologically active compounds derived from prostaglandin endopero'xides[J]. Proc Natl Aead Sci USA, 1975, 72: 2994-2998.
  • 4Roth GJ, Majerus PW. The mechanism of the effect of aspirin on human platelets.I.Acetylation of particulate fraction protein[J]. J Clin Invest, 1975, 56: 624-632.
  • 5Antithrombotic Trialists'Collaboration. Collaboration meta-analysis of randomized trials of antiplatelet therapy for prevention of death,myocardial infartion,and stroke in high risk patients[J]. BMJ, 2002, 324: 71-86.
  • 6Patrono C, Rocca B. Aspirin: promise and resistance in the new millen- nium[J]. Arterioscler Thromb Vasc Biol, 2008, 28: s25-s32.
  • 7Patrono C. Aspirin resistance: definition, mechanisms and clinical read- outs[J]. J Thromb Haemost, 2003, 1: 1710-1713.
  • 8Pusch G, Feher G, Koltai K, et al. Aspirin resistance:focus on clinical endpoints[J]. J Cardiovasc Pharmacol, 2008, 52: 475-484.
  • 9Thpmas C, Corinne F, Jacques Q, et al. Aspirin noncompliance is the majorcau-se of"asprirn resistance" in patients undergoing coronary stenting [J]. Am Heart J, 2009, 157: 889-893.
  • 10Floyd CN, Ferro A. Mechanisms of aspirin resistance [J]. Pharmacol.Ther, 2014, 141: 69-78.

引证文献6

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部